10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001179929-18-000102`
Period End Date	20180331
Filing Date	20180430
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	moh-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 47 Cash Flow Statement 72 Stockholders Equity 29 Comprehensive Income 10

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.20B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.73B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.52B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.44B	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsCurrent`	$77.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsCurrent`	$169.00M	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$950.00M	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$871.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$239.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$411.00M	USD	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$522.00M	USD	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$585.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.51B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.20B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentNet`	$342.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentNet`	$318.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$255.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$250.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$120.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$119.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$103.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$114.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$135.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.00M	USD	Point-in-time
Total assets	`Assets`	$9.13B	USD	Point-in-time
Total assets	`Assets`	$8.47B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.93B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.93B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.19B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.02B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.54B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.71B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$366.00M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$713.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$404.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$282.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$653.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$566.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$522.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$585.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.00B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.56B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.32B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.32B	USD	Point-in-time
Lease financing obligations	`CapitalLeaseObligationsNoncurrent`	$198.00M	USD	Point-in-time
Lease financing obligations	`CapitalLeaseObligationsNoncurrent`	$198.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$61.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$59.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.58B	USD	Point-in-time
Total liabilities	`Liabilities`	$7.13B	USD	Point-in-time
Common stock, $0.001 par value, 150 shares authorized; outstanding: 62 shares at March 31, 2018 and 60 shares at December 31, 2017	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 shares authorized; outstanding: 62 shares at March 31, 2018 and 60 shares at December 31, 2017	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.15B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.04B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-12.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$412.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$298.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.34B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.55B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.47B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$9.13B	USD	Point-in-time

Income Statement 47 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`HealthCareOrganizationPremiumRevenue`	$4.32B	USD	1 Quarter
Premium revenue	`HealthCareOrganizationPremiumRevenue`	$4.65B	USD	1 Quarter
Service revenue	`TechnologyServicesRevenue`	$134.00M	USD	1 Quarter
Service revenue	`TechnologyServicesRevenue`	$131.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$104.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$111.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$61.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$14.00M	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$24.00M	USD	1 Quarter
Total revenue	`Revenues`	$4.65B	USD	1 Quarter
Total revenue	`Revenues`	$4.90B	USD	1 Quarter
Medical care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$4.11B	USD	1 Quarter
Medical care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$3.72B	USD	1 Quarter
Cost of service revenue	`TechnologyServicesCosts`	$120.00M	USD	1 Quarter
Cost of service revenue	`TechnologyServicesCosts`	$122.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$439.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$352.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$111.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$104.00M	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$75.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$26.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$39.00M	USD	1 Quarter
Restructuring and separation costs	`RestructuringCosts`	$234.00M	USD	Annual
Restructuring and separation costs	`RestructuringCosts`	$25.00M	USD	1 Quarter
Restructuring and separation costs	`RestructuringCosts`	-	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.42B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.82B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$222.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$82.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$26.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$33.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-10.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$75.00M	USD	1 Quarter
Total other expenses (income), net	`NonoperatingIncomeExpense`	$-43.00M	USD	1 Quarter
Total other expenses (income), net	`NonoperatingIncomeExpense`	$49.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$131.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$179.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$72.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$54.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.79	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.38	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.37	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.64	USD	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$49.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$37.00M	USD	1 Quarter
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$5.00M	USD	1 Quarter
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$6.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$6.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$6.00M	USD	1 Quarter
Non-cash restructuring costs	`NoncashRestructuringCharges`	$17.00M	USD	1 Quarter
Non-cash restructuring costs	`NoncashRestructuringCharges`	-	USD	1 Quarter
Amortization of convertible senior notes and lease financing obligations	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$7.00M	USD	1 Quarter
Amortization of convertible senior notes and lease financing obligations	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$8.00M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$3.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$2.00M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$83.00M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$32.00M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$12.00M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$239.00M	USD	1 Quarter
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-163.00M	USD	1 Quarter
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-3.00M	USD	1 Quarter
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$373.00M	USD	1 Quarter
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$172.00M	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$50.00M	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$319.00M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$146.00M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$130.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$78.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$59.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$394.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$719.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$389.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$733.00M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$433.00M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$543.00M	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00M	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$26.00M	USD	1 Quarter
Increase in restricted investments held-to-maturity	`IncreaseDecreaseOfRestrictedInvestments`	-	USD	1 Quarter
Increase in restricted investments held-to-maturity	`IncreaseDecreaseOfRestrictedInvestments`	$5.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$5.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$6.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-337.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$145.00M	USD	1 Quarter
Cash paid for financing transaction fees	`PaymentsOfFinancingCosts`	$5.00M	USD	1 Quarter
Cash paid for financing transaction fees	`PaymentsOfFinancingCosts`	-	USD	1 Quarter
Proceeds from employee stock plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.00M	USD	1 Quarter
Proceeds from employee stock plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	-	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.00M	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$534.00M	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$381.00M	USD	1 Quarter
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.82B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.82B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Common stock used for share-based compensation	`StockIssued1`	$6.00M	USD	1 Quarter
Common stock used for share-based compensation	`StockIssued1`	$5.00M	USD	1 Quarter
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Common stock issued in exchange for 1.625% Convertible Notes	`NotesIssued1`	-	USD	1 Quarter
Common stock issued in exchange for 1.625% Convertible Notes	`NotesIssued1`	$131.00M	USD	1 Quarter
Component of 1.625% Convertible Notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	-	USD	1 Quarter
Component of 1.625% Convertible Notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	$-23.00M	USD	1 Quarter
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	1 Quarter
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	1 Quarter

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	60.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	59.00M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Net income	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.00M	USD	1 Quarter
1.625% Convertible Notes exchange transaction	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	1 Quarter
1.625% Convertible Notes exchange transaction	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-7.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.00M	USD	1 Quarter
Ending Balance (in shares)	`SharesOutstanding`	59.00M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	56.00M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.00M	USD	1 Quarter
Unrealized investment (loss) gain	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-7.00M	USD	1 Quarter
Unrealized investment (loss) gain	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-7.00M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$100.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$78.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.